These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1201741)

  • 41. Sequential use of insulin and levodopa to provoke pituitary secretion of growth hormone.
    Reiter EO; Root AW; Duckett GE
    Am J Dis Child; 1977 Feb; 131(2):189-91. PubMed ID: 835536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [HGH secretion after oral application of L-dopa and L-carbidopa (author's transl)].
    Schönberger W; Ziegler R; Brodt B; Grimm W
    Eur J Pediatr; 1976 Jun; 122(3):195-200. PubMed ID: 1278188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alpha adrenergic control of growth hormone in adult male rats.
    Ruch W; Jaton AL; Bucher B; Marbach P; Doepfner W
    Experientia; 1976 Apr; 32(4):529-31. PubMed ID: 1269672
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyproheptadine inhibits the corticotropin releasing hormone (CRH)--induced hormone release in normal subjects.
    Allolio B; Schulte HM; Deuss U; Winkelmann W
    Horm Metab Res Suppl; 1987; 16():36-8. PubMed ID: 2832287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. L-DOPA and pituitary hormone secretion.
    Hayek A; Crawford JD
    J Clin Endocrinol Metab; 1972 May; 34(5):764-6. PubMed ID: 5012491
    [No Abstract]   [Full Text] [Related]  

  • 46. The effect of cyproheptadine on plasma growth hormone (GH) and on somatostatin response to GH-releasing hormone in man.
    Rosskamp RH; Haverkamp F; von Kalckreuth G
    Horm Metab Res; 1990 May; 22(5):295-7. PubMed ID: 1971804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyproheptadine-mediated inhibition of growth hormone and prolactin release from pituitary adenoma cells of acromegaly and gigantism in culture.
    Ishibashi M; Fukushima T; Yamaji T
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):474-80. PubMed ID: 2994332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of serotonin, cyproheptadine and reserpine on corticotropin-releasing factor release from the rat hypothalamus in vitro.
    Nakagami Y; Suda T; Yajima F; Ushiyama T; Tomori N; Sumitomo T; Demura H; Shizume K
    Brain Res; 1986 Oct; 386(1-2):232-6. PubMed ID: 3022879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of cyproheptadine on insulin-induced hypoglycaemia secretion of PRL, GH and cortisol.
    Kletzky OA; Marrs RP; Nicoloff JT
    Clin Endocrinol (Oxf); 1980 Sep; 13(3):231-4. PubMed ID: 7011596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Secretion of human growth hormone and insulin in levodopa test during carbamazepine therapy.
    Syvälahti E; Pynnönen S
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):285-8. PubMed ID: 320826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone.
    Izdebski J; Pinski J; Horvath JE; Halmos G; Groot K; Schally AV
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4872-6. PubMed ID: 7761415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of the degree of short stature on the type of response to tests of pituitary growth hormone reserve].
    Bellastella A; Esposito V; D'Alessandro B; Piccolo C; Officioso N
    Boll Soc Ital Biol Sper; 1978 Dec; 54(24):2565-9. PubMed ID: 756278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Incorporation of L-3-4-dihydroxyphenylalanine (L-Dopa) by various cells of chick embryo anterior pituitary].
    Ferrand R; Miégeville M; Le Douarin N
    C R Acad Hebd Seances Acad Sci D; 1974 Sep; 279(13):1097-100. PubMed ID: 4219316
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of 1-dihydroxyphenylalanine (l-dopa), anesthesia and surgical stress on the secretion of growth hormone in the dog.
    Lovinger RD; Connors MH; Kaplan SL; Ganong WF; Grumbach MM
    Endocrinology; 1974 Nov; 95(5):1317-21. PubMed ID: 4426291
    [No Abstract]   [Full Text] [Related]  

  • 55. Under-responsiveness of growth hormone secretion after L-dopa and deep sleep stimulation in obese subjects.
    Laurian L; Oberman Z; Ayalon D; Cordova T; Herzberg M; Horer E; Harell A
    Isr J Med Sci; 1975 May; 11(5):482-7. PubMed ID: 1158662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histochemical observations on uptake of L-dopa into endocrine cells of the rat pituitary gland during the postnatal development.
    Partanen S; Rechardt L; Bäck N
    Cell Tissue Res; 1975; 156(4):451-61. PubMed ID: 164285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. L-dopa induced growth hormone secretion. Comparison with insulin tolerance test, arginine infusion and sleep induced GH-secretion.
    Lucke C; Höffken B; Morgner KD
    Acta Endocrinol (Copenh); 1974 Oct; 77(2):241-9. PubMed ID: 4479561
    [No Abstract]   [Full Text] [Related]  

  • 58. Elevation of dental pain threshold induced in man by physical exercise is not reversed by cyproheptadine-mediated suppression of growth hormone release.
    Kemppainen P; Pertovaara A; Huopaniemi T; Johansson G
    Neurosci Lett; 1986 Oct; 70(3):388-92. PubMed ID: 3774237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitory effect of serotonin antagonists on growth hormone release in acromegalic patients.
    Feldman JM; Plonk JW; Bivens CH
    Clin Endocrinol (Oxf); 1976 Jan; 5(1):71-8. PubMed ID: 765007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Possible interaction of PGF2 alpha with hypothalamus-pituitary-thyroid axis in man.
    Valenti G; Ceda GP; Tarditi E; Banchini A; Vescovi PP; Chiodera P; Coiro V; Butturini U
    Prostaglandins; 1976 Feb; 11(2):303-17. PubMed ID: 817369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.